References
- Feldberg W., Wei E. The central origin and mechanism of cardiovascular effects of morphine as revealed by naloxone in the rats. J Physiol London 1977; 272: 99p–100p
- Laubie M., Schmitt H., Vincent M., Remond G. Central cardiovascular effects of morphinomimetic peptides in dogs. Eur J Pharmacol 1977; 46: 67–71
- Schaz K., Stock G., Simon W., Schlor K-H., Unger T., Rockhold R., Ganten D. Enkephalin effects on blood pressure, heart rate, and baroreceptor reflex. Hypertension 1980; 2: 395–407
- Hoffmann L. J., Phillips Ian M. Inhibition of angiotensin II pressor effect by naloxone (Abstract). Physiologist 1981; 24: 24
- Szilagyi J. E., Ferrario M. Central opiate system modulation of the area postrema pressor pathway. Hypertension 1981; 3: 313–317
- Summy-Long J. Y., Keil L. C., Sells G., Kirby A., Chee O., Severs W. B. Cerebroventricular sites for enkephalin inhibition in the central actions of angiotensin. Am J Physiol 1983; 244: R522–R529
- Szilagyi J. E., Chelly J., Doursout M-F. Suppression of renin release by antagonism of endogenous opiates in the dog. Am J Physiol 1986; 250: R633–R637
- Lebbie M., Jackson J. W., Szilagyi J. E. Attenuation of the development of renovascular hypertension by blockade of endogenous opiates in the rat. (Abstract) Fed Proc 1987; 46: 670
- Robertson J. I. S., Morton J. J., Tillman D. M., Lever A. F. The pathophysiology of renovascular hypertension. J Hypertension 1986; 4(suppl 4)S95–S103
- Mohring J., Mohring B., Naumann H-J., Philippi A., Homsy E., Orth H., Dauda G., Kazda S., Gross F. Salt and water balance and renin activity in renal hypertension of rats. Am J Physiol 1975; 228: 1847–1855
- Chen M., Lee J., Malvin R. L., Huang B. S. Naloxone attenuates development of hypertension in two-kidney one-clip Goldblatt rats. Am J Physiol 1988; 255: E839–E842
- Webb R. C., Bohr D. F. Recent advances in the pathogenesis of hypotension: consideration of structural, function and metabolic vascular abnormalities resulting in elevated arterial resistance. Am Heart J 1981; 102: 251–264
- Lee C-H., Berkowitz B. A. Stereoselective and calcium-dependent contractile effects of narcotic antagonist analgesics in the vascular smooth muscle of the rat. J Pharmacoi Exper Therap 1976; 193: 347–356
- Ferrario C. M., Gildenberg P. L., McCubbin J. W. Cardiovascular effects of angiotensin mediated by the central nervous system. Cir Res 1972; 30: 257–262
- Summy-Long J. Y., Keil J. C., Deen K., Severs W. B. Opiate regulation of angiotensin-induced drinking and vasopressin release. J Pharmcol Exper Therap 1981; 217: 630–637
- Mendelsohn F. A. O., Ouirion R., Saavedra J. M., Aguilera G., Catt K. J. Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci USA 1984; 81: 1575–1579
- Kuhar M. J., Pert C. B., Snyder S. H. Regional distribution of opiate receptor binding in monkey and human brain. Nature 1973; 245: 447–450
- Ganten D., Unger T., Simon W., Schaz K., Scholkens B., Mann J. F. E., Speck G., Lang R., Rascher W. Central peptidergic stimulation: Focus on cardiovascular actions of angiotensin and opioid peptides. Central nervous system mechanisms in hypertension, J. P. Buckley, C. M. Ferrario, M. F. Lokhandwala. Raven Press, New York 1981; 265–282
- Fink G. D., Brody M. J. Impaired neurogenic control of renal vasculature in renal hypertensive rats. Am J Physiol 1980; 238: H770–H775
- Vanhoutte P. M., Webb R. C., Collis M. G. Pre- and post-junctional adrenergic mechanisms and hypertension. Clin Sci 1980; 59: 211s–223s
- Vanhoutte P. M. The adrenergic neuroeffector interaction in the normotensive and hypertensive blood vessel wall. J Cardiovasc Pharmacol 1980; 2(suppl 3)S253–s267
- Krakoff L. R., de Champlain J., Axelrod J. Abnormal storage of norepinephrine in experimental hypertension in the rat. Cir Res 1967; 21: 583–591
- Webb R. C., Johnson J. C., Bohr D. F. Adrenergic neurotransmission in tail arteries from two-kidney, one clip, renal hypertensive rats. Hypertension 1983; 5: 298–306
- Bickerton R. K., Bumpus F. M., Khairallah P. A. Inhibition of norepinephrine uptake in hearts by angiotensin II and analogs. J Pharmacol Exper Therap 1969; 167: 291–299
- McCubbin J. W., Page I. H. Neurogenic component of chronic renal hypertension. Science 1963; 139: 210–215